SCHEMBL5185652

SCHEMBL5185652

NC(N)(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL3185029 0.91 ALDH1A1 (0.38)
Acetic Acid SCHEMBL28562188 0.88 FFAR3 (0.54)
Acetic Acid SCHEMBL29112702 0.84 FFAR3 (0.50)
SCHEMBL10597855 0.76
SCHEMBL3162376 0.76 ALDH1A1 (0.40)
SCHEMBL2368845 0.76
SCHEMBL395402 0.76 ALDH1A1 (0.40)
SCHEMBL3381190 0.73
SCHEMBL8473334 0.73 ALDH1A1 (0.38)
SCHEMBL3377947 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3739002-B1 PHOTOVOLTAIC ENCAPSULATION MATERIAL WITH HIGH LIGHT TRANSMITTANCE HANGZHOU FIRST APPLIED MAT CO LTD (CN) 2024-01-17 EP disclosed
US-11525043-B2 High light transmittance photovoltaic encapsulating material HANGZHOU FIRST APPLIED MATERIAL CO., LTD. (CN) 2022-12-13 US disclosed
CN-113974160-A Composition for preventing and improving muscle attenuation and application thereof 广州白云山敬修堂药业股份有限公司 2022-01-28 CN disclosed
US-20210115204-A1 HIGH LIGHT TRANSMITTANCE PHOTOVOLTAIC ENCAPSULATING MATERIAL HANGZHOU FIRST APPLIED MATERIAL CO., LTD. (CN) 2021-04-22 US disclosed
EP-3739002-A1 PHOTOVOLTAIC ENCAPSULATION MATERIAL WITH HIGH LIGHT TRANSMITTANCE Hangzhou First Applied Material Co., Ltd. (CN) 2020-11-18 EP disclosed
US-20160257708-A1 ACYLATED 4-AMIDINO- AND 4-GUANIDINOBENZYLAMINES FOR THE INHIBITION OF PLASMA KALLIKREIN CURACYTE CHEMISTRY GMBH (DE) 2016-09-08 US disclosed
US-9365613-B2 Acylated 4-amidino- and -4-guanidinobenzylamines for inhibition of plasma kallikrein THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) 2016-06-14 US disclosed
CN-102648415-A Quantitative fluorescent protein standard LIFE TECHNOLOGIES CORP 2012-08-22 CN disclosed
EP-1403381-B1 IMPROVED METHOD FOR DETECTING AND IDENTIFYING MICROORGANISM CAUSATIVE OF INFECTION FUSO PHARMACEUTICAL IND (JP) 2007-07-11 EP disclosed
US-20060148901-A1 Acylated 4-amidino-and-4-guanidinobenzylamines for inhibition of plasma kallikrein THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) 2006-07-06 US disclosed
EP-1403381-A1 IMPROVED METHOD FOR DETECTING AND IDENTIFYING MICROORGANISM CAUSATIVE OF INFECTION FUSO PHARMACEUTICAL INDUSTRIES LTD. (JP) 2004-03-31 EP disclosed